Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

A reliable model for screening type II 5α-reductase inhibitors was created and validated.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Different countries have their own rules for natural products used in beauty and personal care.

QMSI effectively maps and quantifies drug distribution in skin tissues.

Equilibrium dialysis can accurately measure testosterone levels when lab results are inconsistent.

The new topical growth hormone formula has high skin penetration and bioavailability.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Ethosomes improve drug delivery through the skin and show promise for treating male pattern baldness.

Drugs can be incorporated into hair based on their chemical properties and hair pigmentation.

The UV–Vis Spectrophotometry method effectively measures minoxidil in rat skin for alopecia treatment.

The method accurately measures 19 steroid hormones in human blood and urine using a small sample and is suitable for large-scale monitoring.

A new method was created to accurately measure minoxidil and aminexil in hair loss treatments.

CG2001 is safe and well-tolerated for treating hair loss in men.

Farmácias de manipulação precisam melhorar o controle de qualidade do Minoxidil.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

In vitro methods for testing cosmeceuticals need improvement for better human relevance and reliability.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

A new method accurately measures finasteride levels in human plasma.

The article concludes that products can affect the body without being drugs as long as they don't claim to treat or prevent diseases, except for cosmetic sunscreens.

The FDA rejected a testosterone drug again due to safety concerns.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Best results found using acetonitrile, water, and trifluoroacetic acid or methanol mixture.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

UHP-sCESr is as effective as HESr for treating BPH symptoms.